Cargando…
Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis
Background: Optimal heart rate (HR) that associates with higher cardiac output and greater clinical outcomes in patients with cardiac amyloidosis remains unknown. Methods: Consecutive patients with sinus rhythm who were diagnosed with cardiac amyloidosis at our institute between February 2015 and Fe...
Autores principales: | Izumida, Toshihide, Imamura, Teruhiko, Nakamura, Makiko, Kinugawa, Koichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706408/ https://www.ncbi.nlm.nih.gov/pubmed/34940536 http://dx.doi.org/10.3390/jcdd8120182 |
Ejemplares similares
-
How to consider target heart rate in patients with systolic heart failure
por: Izumida, Toshihide, et al.
Publicado: (2020) -
Combination therapy using tafamidis and neurohormonal blockers for cardiac amyloidosis and a reduced ejection fraction: a case report
por: Imamura, Teruhiko, et al.
Publicado: (2022) -
Prognostic Impact of the Increase in Cardiac Troponin Levels during Tafamidis Therapy in Patients with Transthyretin Cardiac Amyloidosis
por: Nakamura, Makiko, et al.
Publicado: (2023) -
Acute Heart Failure in a Patient with Occult Barlow’s Disease Receiving Bevacizumab
por: Izumida, Toshihide, et al.
Publicado: (2021) -
Patient Selection for Pemafibrate Therapy to Prevent Adverse Cardiovascular Events
por: Izumida, Toshihide, et al.
Publicado: (2022)